Compugen (CGEN) Net Margin (2009 - 2026)

Compugen's (CGEN) quarterly Net Margin came in at 351.98% in Q1 2026, up 4029.0% year-on-year from 8.52% in Q1 2025, and up 317.7% quarter-over-quarter from 84.26% in Q4 2025.

Compugen (CGEN) Net Margin (2009 - 2026) Analysis & Trends

Compugen has disclosed Net Margin across 15 years of filings, most recently posting 351.98% for Q1 2026.

  • Net Margin for Q1 2026 came in at 351.98%, up 4029.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 49.39% (up 6873.0% YoY), and the FY2025 annual result was 48.57%, up 9965.0% from the prior year.
  • Net Margin came in at 351.98% for Q1 2026 at Compugen, up from 84.26% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 351.98% in Q1 2026 to a low of 1719.49% in Q2 2025.
  • The 5-year median for Net Margin is 29.03% (2023), against an average of 151.7%.
  • Peak annual rise in Net Margin reached 50010 bps in 2025, while the deepest fall reached 147146 bps in 2025.
  • Compugen's Net Margin stood at 41.23% in 2022, then surged by 170 bps to 29.03% in 2023, then slumped by 1532 bps to 415.84% in 2024, then soared by 120 bps to 84.26% in 2025, then jumped by 318 bps to 351.98% in 2026.
  • The last three Net Margin figures came in at 351.98% (Q1 2026), 84.26% (Q4 2025), and 364.83% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 351.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 351.98%
Dec 31, 2025 84.26%
Sep 30, 2025 -364.83%
Jun 30, 2025 -1,719.49%
Mar 31, 2025 311.69%
Dec 31, 2024 -415.84%
Sep 30, 2024 60.03%
Jun 30, 2024 -248.03%
Mar 31, 2024 283.74%
Dec 31, 2023 29.03%
Dec 31, 2022 -41.23%
Sep 30, 2021 -136.27%
Dec 31, 2020 -428.15%
Sep 30, 2018 -39.88%
Mar 31, 2018 1.04%
Dec 31, 2016 -0.02%
Sep 30, 2016 -11,115.71%
Jun 30, 2016 -1,333.06%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -5.68%